EFTR Stock Earnings: eFFECTOR Therapeutics Meets EPS for Q1 2024

eFFECTOR Therapeutics (NASDAQ:EFTR) just reported results for the first quarter of 2024.eFFECTOR Therapeutics reported earnings per share of -$2.16. This met the analyst estimate for EPS of -$2.16.The company did not report any revenue for the quarter.InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst es ...